Omega Operating Cash Flow Per Share vs Book Value Per Share Analysis
| OMGA Stock | USD 0.80 0.06 6.98% |
Omega Therapeutics financial indicator trend analysis is much more than just breaking down Omega Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omega Therapeutics is a good investment. Please check the relationship between Omega Therapeutics Operating Cash Flow Per Share and its Book Value Per Share accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.
Operating Cash Flow Per Share vs Book Value Per Share
Operating Cash Flow Per Share vs Book Value Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omega Therapeutics Operating Cash Flow Per Share account and Book Value Per Share. At this time, the significance of the direction appears to have pay attention.
The correlation between Omega Therapeutics' Operating Cash Flow Per Share and Book Value Per Share is -0.75. Overlapping area represents the amount of variation of Operating Cash Flow Per Share that can explain the historical movement of Book Value Per Share in the same time period over historical financial statements of Omega Therapeutics, assuming nothing else is changed. The correlation between historical values of Omega Therapeutics' Operating Cash Flow Per Share and Book Value Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Cash Flow Per Share of Omega Therapeutics are associated (or correlated) with its Book Value Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value Per Share has no effect on the direction of Operating Cash Flow Per Share i.e., Omega Therapeutics' Operating Cash Flow Per Share and Book Value Per Share go up and down completely randomly.
Correlation Coefficient | -0.75 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most indicators from Omega Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omega Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.At present, Omega Therapeutics' Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 301.7 M, whereas Selling General Administrative is forecasted to decline to about 16.5 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 910K | 222K | 199.8K | 189.8K | Depreciation And Amortization | 1.4M | 5.2M | 6.8M | 7.1M |
Omega Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Omega Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Omega Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Therapeutics Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Revenue Per Share 0.114 | Quarterly Revenue Growth 1.812 | Return On Assets (0.25) | Return On Equity (1.29) |
The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.